Medicus Pharma restores Nasdaq compliance; stock rises premarket
- Medicus Pharma (MDCX) announced Monday that it regained compliance with Nasdaq’s $1 minimum bid price requirement.
- Nasdaq confirmed compliance after the stock’s closing bid price remained at or above $1 for 10 consecutive business days, from October 12 to October 23.
- The company remains subject to other Nasdaq's other listing requirements and may not maintain compliance in the future.
- On the market side, MDCX stock traded ~3.20% higher at ~$2.58 in the premarket session.
Recommended For You
Create Your Free Account to Keep Reading
Get the confidence to navigate an uncertain market with free breaking news and stock alerts.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.